|
Additional information - this emdr is being submitted to include the below: h6: investigation results under type of investigation, investigation findings, investigation conclusions.H11: investigation summary.Photograph, video and/or physical sample evaluation: no photograph associated with this case was received.No return sample has been received for this complaint.Batch record revision results: - packaging and assembly process performed in the aps 6 line: lot 5a03066 was manufactured on 15/jan/2025, in aps 6 auto manufacturing line, with a total of 518 market units (mkus).The complaint engineer performed a batch record review on 01/dec/2025, to verify if all the applicable procedures were followed and no issues were found; all the components for assembly were correct per bill of materials (bom), and all the tooling information documented was also correct, system application product (sap) material identification (id)1708122 and manufacturing order (b)(4).The production process, in-process control, testing results, and packaging of products were run according to the process instruction (pi).- trilamination process performed in the esteem cmt line: the subassembly 4l05387, order (b)(4), material 1707112 was manufactured on 03/dec/2024 in the esteem cmt line.The complaints engineer performed a batch record review on 01/dec/2025, and it was confirmed that the applicable procedures were followed, the materials were correct as per bom, and the equipment settings were according to the process instruction.- extrusion, lamination & cutting process (elc) performed in the elc #7 line: the subassembly 4l03168, order (b)(4), material 1707789 was manufactured on 15/nov/2024 in the elc #7 line.The complaints engineer id (b)(4) performed a batch record review on 01/dec/2025, and it was confirmed that the applicable procedures were followed, the materials were correct as per bom, and the equipment settings were according to the process instruction (pi).The subassembly 4l05457, order (b)(4), material 1707789 was manufactured on 27/nov/2024 in the elc #7 line.The complaints engineer performed a batch record review on 01/dec/2025, and it was confirmed that the applicable procedures were followed, the materials were correct as per bom, and the equipment settings were according to the process instruction (pi).The subassembly 4l04294, order (b)(4), material 1707790 was manufactured on 21/nov/2024 in the elc #7 line.The complaints engineer performed a batch record review on 01/dec/2025, and it was confirmed that the applicable procedures were followed, the materials were correct as per bom, and the equipment settings were according to the process instruction (pi).Historical complaints review: on 01/dec/2025, the complaints engineer ran a query in database to verify the complaints reported for the lot 5a03066 and the malfunction ¿skin barrier does not mold around stoma (e.G too stiff, too dry, tears /crumbles when molding) at point of application¿ and as result any additional complaint was identified during this search as per work instructions (wi).Historical nonconformance review: on 01/dec/2025, the complaints engineer ran a query in database looking for any in process nonconformance / corrective and preventive actions (capa) (s) associated to the malfunction ¿skin barrier does not mold around stoma (e.G too stiff, too dry, tears /crumbles when molding) at point of application¿ for lots number 5a03066, 4l05387, 4l03168, 4l05457, 4l04294.As a result, no nonconformance / capas for this malfunction were generated during the manufacturing process of the referenced lots.Current quality controls: based on the process instruction (pi), the following tests are performed in the elc #7 manufacturing lines, in order to identify this failure mode in our manufacturing process: (b)(4).Defect rate analysis: there have been 5 defective parts confirmed to date from a lot size (b)(4) products.This represents a defect rate of only (b)(4), which is well within an appropriate acceptable quality level (aql) for this defect which should be (b)(4) based on our standard operating procedure (sop).In addition, all of the in-process testing on this lot did not find a single defective pouch, which confirms that the lot is unlikely to breach an aql of (b)(4).This issue certainly appears to be an isolated incident, but more importantly to date, it is well within our accepted aql level for this type of failure mode or defect.Conclusion: a batch record review was conducted for the final product lot 5a03066, including the bulk lots (4l05387, 4l03168, 4l05457, 4l04294), confirming that all relevant tests required during the manufacturing process and final product release were completed and met the necessary standards.No discrepancies or capas related to this issue were identified in the documentation and equipment used during testing was within calibration, ensuring the reliability of the results.Additionally, a defect rate analysis was performed, and the affected quantity falls within the acceptable aql for this type of defect.No changes to the end-to-end manufacturing process or components used during assembly of the batch were performed.This issue will be monitored through the post market product monitoring review process, standard operating procedure (sop).To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number: reporting site: 1049092.Manufacturing site: 9618003.
|